Dampening the effect of drug resistance in HIV: a leap forward - PubMed (original) (raw)
Comment
Dampening the effect of drug resistance in HIV: a leap forward
Jens D Lundgren et al. Lancet Infect Dis. 2012 Feb.
No abstract available
Comment on
- Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study.
Pursuing Later Treatment Option II (PLATO II) project team; Observational HIV Epidemiological Research Europe (COHERE) Group; Costagliola D, Lodwick R, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, Touoloumi G, Mussini C, Castagna A, Stephan C, García F, Zangerle R, Duval X, Pérez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Phillips A. Pursuing Later Treatment Option II (PLATO II) project team, et al. Lancet Infect Dis. 2012 Feb;12(2):119-27. doi: 10.1016/S1473-3099(11)70248-1. Epub 2011 Oct 9. Lancet Infect Dis. 2012. PMID: 21988895
Similar articles
- Drug resistance among patients recently infected with HIV.
Epstein BJ. Epstein BJ. N Engl J Med. 2002 Dec 5;347(23):1889-90; author reply 1889-90. doi: 10.1056/NEJM200212053472315. N Engl J Med. 2002. PMID: 12466517 No abstract available. - HIV drug resistance and you. Resistance testing in experienced patients. Considerations when changing drugs.
[No authors listed] [No authors listed] Posit Aware. 2006 Winter;Spec No:17-22. Posit Aware. 2006. PMID: 16596730 No abstract available. - Drug resistance mutations in HIV-1.
D'Aquila RT, Schapiro JM, Brun-Vézinet F, Clotet B, Conway B, Demeter LM, Grant RM, Johnson VA, Kuritzkes DR, Loveday C, Shafer RW, Richman DD. D'Aquila RT, et al. Top HIV Med. 2003 May-Jun;11(3):92-6. Top HIV Med. 2003. PMID: 12837968 No abstract available. - Update of the drug resistance mutations in HIV-1: 2004.
Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman DD. Johnson VA, et al. Top HIV Med. 2004 Oct-Nov;12(4):119-24. Top HIV Med. 2004. PMID: 15516709 Review. No abstract available. - Update of the drug resistance mutations in HIV-1: 2007.
Johnson VA, Brun-Vézinet F, Clotet B, Günthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD. Johnson VA, et al. Top HIV Med. 2007 Aug-Sep;15(4):119-25. Top HIV Med. 2007. PMID: 17720996 Review. No abstract available.
Cited by
- HIV Drug Resistance: Problems and Perspectives.
Pennings PS. Pennings PS. Infect Dis Rep. 2013 Jun 6;5(Suppl 1):e5. doi: 10.4081/idr.2013.s1.e5. eCollection 2013 Jun 6. Infect Dis Rep. 2013. PMID: 24470969 Free PMC article. Review. - Knowledge of HIV and its treatment among health care providers in South Africa.
Ruud KW, Srinivas SC, Toverud EL. Ruud KW, et al. Int J Clin Pharm. 2014 Apr;36(2):352-9. doi: 10.1007/s11096-013-9902-9. Epub 2013 Dec 24. Int J Clin Pharm. 2014. PMID: 24366678 - Respiratory virus modulation of host nucleocytoplasmic transport; target for therapeutic intervention?
Caly L, Ghildyal R, Jans DA. Caly L, et al. Front Microbiol. 2015 Aug 14;6:848. doi: 10.3389/fmicb.2015.00848. eCollection 2015. Front Microbiol. 2015. PMID: 26322040 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical